Clinical Trial Update: A Study in Healthy People to Test Whether BI 730357 Influences the Amount of Caffeine, Warfarin, Omeprazole, and Midazolam in the Blood [Phase 1]

View source ↗

Summary

Phase 1 study assessing how BI 730357 affects blood levels of caffeine, warfarin, omeprazole, and midazolam in healthy participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Individuals

Drugs mentioned

• BI 730357

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2023-07-17